Abrams R, Essman W B, Taylor M A, Fink M
Biol Psychiatry. 1976 Feb;11(1):85-90.
Cerebrospinal fluid (CSF) levels of 5-hydroxyindoleacetic acid (5HIAA), tryptophan (TRYP), and homovanillic acid (HVA), were determined prior to electroconvulsive therapy (ECT) and after an average course of 6.7 ECT in six endogenous depressed patients. Depression rating scale (DRS) scores were also obtained by a "blind" research psychiatrist before and after ECT at the time of each lumbar puncture. ECT markedly reduced DRS scores but did not significantly alter CSF levels of 5HIAA, TRYP, or HVA. We found no correlation between ECT-induced DRS score reductions and changes in any of the CSF constituents studied, or between the absolute DRS score and the corresponding CSF concentration of any of the compounds. These data are consistent with those previously reported for ECT and do not suggest that ECT alters cerebral amine metabolism in depressed patients. Neither do they provide any evidence for direct amine mediation of the depression-relieving effects of ECT in man, nor for any relation between severity of depressive illness and CSF concentrations of 5HIAA, TRYP, or HVA.
在六名内源性抑郁症患者接受电休克治疗(ECT)之前以及平均接受6.7次ECT疗程之后,测定了其脑脊液(CSF)中5-羟吲哚乙酸(5HIAA)、色氨酸(TRYP)和高香草酸(HVA)的水平。在每次腰椎穿刺时,由一位“不知情”的研究精神科医生在ECT前后获取抑郁评定量表(DRS)评分。ECT显著降低了DRS评分,但并未显著改变CSF中5HIAA、TRYP或HVA的水平。我们发现ECT引起的DRS评分降低与所研究的任何CSF成分的变化之间,以及绝对DRS评分与任何一种化合物的相应CSF浓度之间均无相关性。这些数据与先前报道的ECT数据一致,并不表明ECT会改变抑郁症患者的脑胺代谢。它们既没有为ECT在人体中缓解抑郁作用的直接胺介导提供任何证据,也没有为抑郁疾病的严重程度与CSF中5HIAA、TRYP或HVA浓度之间的任何关系提供证据。